Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Funding Crisis Hits China Life Sciences Industry, But China Is Faring Better Than The West

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Pitching her company to a group of potential investors in Hong Kong during the ChinaBio Investor Forum, Carrie Yuen painted a glowing picture of the potential of the Chinese market for medical devices
Advertisement

Related Content

Shanghai Issues New Policy To Draw Venture Capitalists and Private Equity Funds To China
Shanghai Issues New Policy To Draw Venture Capitalists and Private Equity Funds To China
Lack Of Funding and Political Will Hinders Hong Kong’s Untapped Drug Discovery Research – ChinaBio Investor Forum
Chinese Regulatory Changes Key To Life Sciences Investment Decisions – BioMedical Asia
Chinese Regulatory Changes Key To Life Sciences Investment Decisions – BioMedical Asia
Advertisement
UsernamePublicRestriction

Register

SC070878

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel